The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective study for usefulness of circulating-free DNA on prediction of third generation EGFR tyrosine kinase inhibitors.
 
Hironori Yoshida
No Relationships to Disclose
 
Chiho Nakashima
No Relationships to Disclose
 
Naohisa Matsumoto
No Relationships to Disclose
 
Kentaro Iwanaga
No Relationships to Disclose
 
Noriyuki Ebi
No Relationships to Disclose
 
Akihiro Nishiyama
No Relationships to Disclose
 
Kazuhiro Yatera
No Relationships to Disclose
 
Minoru Fukuda
No Relationships to Disclose
 
Sunao Ushijima
No Relationships to Disclose
 
Hitomi Umeguchi
No Relationships to Disclose
 
Daijiro Harada
No Relationships to Disclose
 
Shoichi Kuyama
No Relationships to Disclose
 
Kosuke Kashiwabara
No Relationships to Disclose
 
Takayuki Suetsugu
No Relationships to Disclose
 
Nobukazu Fujimoto
Honoraria - Astellas Pharma; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Ono Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb; Ono Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Kissei Pharmaceutical (Inst); Kyorin (Inst); MSD (Inst); Ono Pharmaceutical (Inst)
 
Katsumi Nakatomi
No Relationships to Disclose
 
Fumihiro Tanaka
No Relationships to Disclose
 
Hidetaka Uramoto
No Relationships to Disclose
 
Chiharu Yoshii
No Relationships to Disclose
 
Naoko Sueoka-Aragane
Research Funding - AstraZeneca Japan